Shell Asset Management CO Ocugen, Inc. Transaction History

Shell Asset Management CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$1.83 - $3.45 $18,155 - $34,227	-9,921 Closed	0 $0
Q1 2022 May 04, 2022	SELL	$2.34 - $4.72 $3,645 - $7,353	-1,558 Reduced 13.57%	9,921 $33,000
Q4 2021 Feb 09, 2022	SELL	$4.38 - $15.67 $459 - $1,645	-105 Reduced 0.91%	11,479 $52,000
Q3 2021 Nov 04, 2021	SELL	$6.36 - $8.51 $2,925 - $3,914	-460 Reduced 3.82%	11,584 $83,000
Q2 2021 Aug 12, 2021	BUY	$5.52 - $15.68 $66,482 - $188,849	12,044 New	12,044 $97,000

124

78.3M

535K

523K

Ticker OCGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,566,000
Market Cap $169M
Description
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

Stay updated on Shell Asset Management CO with notifications on news.